Targeting mitochondrial energetics reverses panobinostat- and marizomib-induced resistance in pediatric and adult high-grade gliomas.
Saved in:
| Title: | Targeting mitochondrial energetics reverses panobinostat- and marizomib-induced resistance in pediatric and adult high-grade gliomas. |
|---|---|
| Authors: | Jane EP; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, PA, USA., Reslink MC; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA., Gatesman TA; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, PA, USA., Halbert ME; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, PA, USA., Miller TA; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA., Golbourn BJ; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA., Casillo SM; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, PA, USA., Mullett SJ; Department of Pharmacology and Chemical Biology, University of Pittsburgh, PA, USA., Wendell SG; Department of Pharmacology and Chemical Biology, University of Pittsburgh, PA, USA., Obodo U; Department of Diabetes & Cancer Metabolism, City of Hope Medical Center, Duarte, CA, USA., Mohanakrishnan D; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA., Dange R; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA., Michealraj A; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA., Brenner C; Department of Diabetes & Cancer Metabolism, City of Hope Medical Center, Duarte, CA, USA., Agnihotri S; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Premkumar DR; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Pollack IF; Department of Neurosurgery, University of Pittsburgh School of Medicine, PA, USA.; John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA. |
| Source: | Molecular oncology [Mol Oncol] 2023 Sep; Vol. 17 (9), pp. 1821-1843. Date of Electronic Publication: 2023 May 12. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1878-0261 |
|---|---|
| DOI: | 10.1002/1878-0261.13427 |
